• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑龙江省输入性甲型流感感染与未感染的俄罗斯籍新冠肺炎重症及危重症患者比较:一项回顾性研究

Comparison of severe and critical COVID-19 patients imported from Russia with and without influenza A infection in Heilongjiang Province: a retrospective study.

作者信息

Dai Qingqing, Ye Ming, Tang Zhiqiang, Yu Kaijiang, Gao Yang, Yang Zhenyu, Zheng Junbo, Zuo Shu, Liu Yan, Xie Fengjie, Han Qiuyuan, He Hua, Wang Hongliang

机构信息

Department of Critical Care Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Department of Critical Care Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin, China.

出版信息

Ann Transl Med. 2021 Sep;9(18):1446. doi: 10.21037/atm-21-3912.

DOI:10.21037/atm-21-3912
PMID:34733998
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8506785/
Abstract

BACKGROUND

The rapid spread of coronavirus disease-19 (COVID-19) poses a global health emergency, and cases entering China from Russia are quite diverse. This study explored and compared the clinical characteristics and outcomes of severe and critically ill COVID-19 patients from Russia with and without influenza A infection, treated in a northern Chinese hospital (Russia imported patients).

METHODS

A total of 32 severe and critically ill Russia-imported COVID-19 patients treated in the Heilongjiang Imported Severe and Critical COVID-19 Treatment Center from April 6 to May 11, 2020 were included, including 8 cases (group A) with and 24 cases (group B) without influenza A infection. The clinical characteristics of each group were compared, including prolonged hospital stay, duration of oxygen therapy, time from onset to a negative SARS-CoV-2 qRT-PCR RNA (T) result, and duration of bacterial infection.

RESULTS

The results showed that blood group, PaO/FiO, prothrombin time (PT), prothrombin activity (PTA), computed tomography (CT) score, hospital stay, duration of oxygenation therapy, T, and duration of bacterial infection were statistically different between the two groups (P<0.05). Multivariant regression analysis showed that the Sequential Organ Failure Assessment (SOFA) score, C-reactive protein (CRP), and influenza A infection were factors influencing hospital stay; SOFA score, CRP, and CT score were factors influencing the duration of oxygenation therapy; PaO/FiO, platelet count (PLT), and CRP were factors influencing T; and gender, SOFA score, and influenza A infection were factors influencing the duration of bacterial infection.

CONCLUSIONS

Influenza A infection is common in Russia-imported COVID-19 patients, which can prolong the hospital stay and duration of bacterial infection. Routinely screening and treating influenza A should be conducted early in such patients.

摘要

背景

新型冠状病毒肺炎(COVID-19)的迅速传播构成了全球卫生紧急事件,从俄罗斯输入中国的病例情况颇为多样。本研究探讨并比较了在中国北方一家医院接受治疗的合并或未合并甲型流感感染的俄罗斯输入型重症及危重症COVID-19患者的临床特征及预后情况(俄罗斯输入患者)。

方法

纳入2020年4月6日至5月11日在黑龙江省输入型重症及危重症COVID-19救治中心接受治疗的32例俄罗斯输入型重症及危重症COVID-19患者,其中合并甲型流感感染的8例(A组),未合并甲型流感感染的24例(B组)。比较两组的临床特征,包括住院时间延长、氧疗时间、从发病到严重急性呼吸综合征冠状病毒2定量逆转录聚合酶链反应(SARS-CoV-2 qRT-PCR)RNA检测结果呈阴性的时间(T)以及细菌感染持续时间。

结果

结果显示,两组之间血型、动脉血氧分压/吸氧浓度(PaO/FiO)、凝血酶原时间(PT)、凝血酶原活动度(PTA)、计算机断层扫描(CT)评分、住院时间、氧疗持续时间、T以及细菌感染持续时间存在统计学差异(P<0.05)。多变量回归分析显示,序贯器官衰竭评估(SOFA)评分、C反应蛋白(CRP)以及甲型流感感染是影响住院时间的因素;SOFA评分、CRP以及CT评分是影响氧疗持续时间的因素;PaO/FiO、血小板计数(PLT)以及CRP是影响T的因素;性别、SOFA评分以及甲型流感感染是影响细菌感染持续时间的因素。

结论

甲型流感感染在俄罗斯输入型COVID-19患者中较为常见,可延长住院时间及细菌感染持续时间。对此类患者应尽早进行甲型流感的常规筛查及治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c888/8506785/56a3034e1499/atm-09-18-1446-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c888/8506785/56a3034e1499/atm-09-18-1446-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c888/8506785/56a3034e1499/atm-09-18-1446-f1.jpg

相似文献

1
Comparison of severe and critical COVID-19 patients imported from Russia with and without influenza A infection in Heilongjiang Province: a retrospective study.黑龙江省输入性甲型流感感染与未感染的俄罗斯籍新冠肺炎重症及危重症患者比较:一项回顾性研究
Ann Transl Med. 2021 Sep;9(18):1446. doi: 10.21037/atm-21-3912.
2
Clinical features of 375 COVID-19 cases imported from Russia through the Suifenhe port and countermeasures.绥芬河口岸入境 375 例俄罗斯输入新冠肺炎病例的临床特点及对策
PLoS One. 2021 Dec 16;16(12):e0261437. doi: 10.1371/journal.pone.0261437. eCollection 2021.
3
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
4
Comparison of demographic features and laboratory parameters between COVID-19 deceased patients and surviving severe and critically ill cases.新冠死亡患者与重症和危重症存活患者的人口统计学特征及实验室参数比较。
World J Clin Cases. 2022 Aug 16;10(23):8161-8169. doi: 10.12998/wjcc.v10.i23.8161.
5
[Risk factors analysis of acute respiratory distress syndrome in intensive care unit traumatic patients].[重症监护病房创伤患者急性呼吸窘迫综合征的危险因素分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Oct;30(10):978-982. doi: 10.3760/cma.j.issn.2095-4352.2018.010.015.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
[Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].血必净联合人免疫球蛋白治疗新型冠状病毒肺炎重型及危重型患者的临床价值评估
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Apr;33(4):399-404. doi: 10.3760/cma.j.cn121430-20200628-00490.
8
[Clinical characteristics and prognosis analysis of 37 patients with severe influenza].37例重症流感患者的临床特征及预后分析
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Oct;32(10):1253-1256. doi: 10.3760/cma.j.cn121430-20200428-00344.
9
Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19).病毒性脓毒症是新型冠状病毒肺炎(COVID-19)患者的一种并发症。
Med Drug Discov. 2020 Dec;8:100057. doi: 10.1016/j.medidd.2020.100057. Epub 2020 Jul 24.
10
[Clinical characteristics and prognostic factors of adult patients with acute respiratory failure due to influenza infection].[流感感染所致成人急性呼吸衰竭患者的临床特征及预后因素]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Nov;32(11):1304-1309. doi: 10.3760/cma.j.cn121430-20200827-00598.

本文引用的文献

1
Early bacterial co-infection in ARDS related to COVID-19.与新型冠状病毒肺炎相关的急性呼吸窘迫综合征中的早期细菌合并感染
Intensive Care Med. 2020 Sep;46(9):1787-1789. doi: 10.1007/s00134-020-06165-5. Epub 2020 Jul 13.
2
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.COVID-19 肺炎患者中标记的 T 细胞激活、衰老、衰竭和向 TH17 的倾斜。
Nat Commun. 2020 Jul 6;11(1):3434. doi: 10.1038/s41467-020-17292-4.
3
COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
COVID-19 不同于 SARS-CoV-2 阴性社区获得性肺炎。
Front Cell Infect Microbiol. 2020 Jun 16;10:322. doi: 10.3389/fcimb.2020.00322. eCollection 2020.
4
Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19.ABO 血型分布与 COVID-19 患者临床特征的关系。
Clin Chim Acta. 2020 Oct;509:220-223. doi: 10.1016/j.cca.2020.06.026. Epub 2020 Jun 17.
5
Hematological features of persons with COVID-19.新型冠状病毒肺炎患者的血液学特征。
Leukemia. 2020 Aug;34(8):2163-2172. doi: 10.1038/s41375-020-0910-1. Epub 2020 Jun 11.
6
Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.基于实验室检测结果建立预测 COVID-19 结局的模型。
Travel Med Infect Dis. 2020 Jul-Aug;36:101782. doi: 10.1016/j.tmaid.2020.101782. Epub 2020 Jun 8.
7
Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.比较分析 COVID-19 重症与非重症患者的实验室指标。
Clin Chim Acta. 2020 Oct;509:180-194. doi: 10.1016/j.cca.2020.06.009. Epub 2020 Jun 6.
8
Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.2019年冠状病毒病(COVID-19)严重患者的淋巴细胞减少症:系统评价与荟萃分析
J Intensive Care. 2020 May 24;8:36. doi: 10.1186/s40560-020-00453-4. eCollection 2020.
9
Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7).新型冠状病毒肺炎诊疗方案(试行第七版)
Chin Med J (Engl). 2020 May 5;133(9):1087-1095. doi: 10.1097/CM9.0000000000000819.
10
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.COVID-19 患者严重呼吸衰竭的复杂免疫失调。
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. doi: 10.1016/j.chom.2020.04.009. Epub 2020 Apr 21.